Efficacy and safety of anlotinib combined with toripalimab in the treatment of advanced non-small cell lung cancer with driver genes negative
| Just accepted | Online first | Issue | Totals | |
|---|---|---|---|---|
| HTML pages views | 0 | 0 | 40 | 40 |
| PDF downloads | 0 | 0 | 12 | 12 |
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.
|